Actively Recruiting
7.0T Magnetic Resonance Imaging Study of Parkinson's Disease
Led by Chinese PLA General Hospital · Updated on 2024-11-08
200
Participants Needed
1
Research Sites
434 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial study is conducted to detect the imaging characteristics of the patients with Parkinson's diseases (PD) by 7-Tesla (7T) magnetic resonance imaging (MRI).
CONDITIONS
Official Title
7.0T Magnetic Resonance Imaging Study of Parkinson's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with Parkinson's disease by an experienced neurologist specializing in movement disorders
You will not qualify if you...
- Patients with brain disorders such as cerebrovascular disease, brain tumors, epilepsy, or other neurodegenerative diseases
- Patients with psychiatric disorders that impair cognitive function
- Patients with contraindications to MRI
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chinese PLA General Hospital
Beijing, Beijing, China, China, 100853
Actively Recruiting
Research Team
H
Haoxaun Lu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here